Stock Price Quote

ENTERO HEALTHCARE SOLUTIONS LTD.

NSE : ENTEROBSE : 544122ISIN CODE : INE010601016Industry : TradingHouse : Private
BSE1169.8529.75 (+2.61 %)
PREV CLOSE ( ) 1140.10
OPEN PRICE ( ) 1137.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4543
TODAY'S LOW / HIGH ( )1137.75 1204.80
52 WK LOW / HIGH ( )974.45 1258
NSE1170.7030.7 (+2.69 %)
PREV CLOSE( ) 1140.00
OPEN PRICE ( ) 1138.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1170.70 (15)
VOLUME 53596
TODAY'S LOW / HIGH( ) 1138.95 1206.00
52 WK LOW / HIGH ( )970 1258
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-01 2018
Management Info
Sujesh Vasudevan - Chairman Prabhat Agrawal - Managing Director
Registered Office

Address Plot No. I-35, Building - B,Industrial Area Phase - I,13/7 Mathura Road,
Faridabad,
Haryana-121003

Phone

Email jayant.prakash@enterohealthcare.com

Website www.enterohealthcare.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

13Mar Substantial Acquisition of Shares
Inter alia, approved:- 1) Acquisition of balance 12,00,000 Equity Shar..
11Mar Macrotech Developers, Tata Technologie
Macrotech Developers has raised Rs 3,300 crore by selling shares to inst..
11Mar Appointment Of Ernst & Young (EY) LLP
Appointment of Ernst & Young (EY) LLP as Internal Auditor of the Company
09Mar Entero Healthcare Solutions gets nod t
Entero Healthcare Solutions has received approval to acquire balance 12,..
09Mar Entero Healthcare inform about investo
Entero Healthcare has informed about disclosure of Investor conference s..

Financials

in Millions
QTR Dec 23 ANNUAL
Net Profit9.47000000000009
Gross Profit 6.98000000000009
Operating Profit 77.5200000000001
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

The Yamuna Syndicate (BSE)
peergroup  27379.90 (3.32%)
M.Cap ( in Cr)841.56
Simplex Mills Co (BSE)
peergroup  4539.50 (4.36%)
M.Cap ( in Cr)13.62
Meson Valves India (BSE)
peergroup  996.65 (5.00%)
M.Cap ( in Cr)1012.60
Halder Venture (BSE)
peergroup  567.95 (4.97%)
M.Cap ( in Cr)179.51
TCC Concept (BSE)
peergroup  576.70 (3.63%)
M.Cap ( in Cr)1270.72

Shareholding Pattern

PROMOTERS 52.44%
NON-INSTITUTION 21.99%
FI/BANKS/INSURANCE 1.13%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Entero Healthcare Solutions Ltd.

Entero Healthcare Solutions Ltd. was incorporated in the year 2018. Its today's share price is 1169.85. Its current market capitalisation stands at Rs 5088.12 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1776.9 Cr and Total Income of Rs.2302.56 Cr. The company's management includes Arun Sadhanandham, Sumona Chakraborty, Prabhat Agrawal, Jayant Prakash, Sandhya Sharma, Rajesh Shashikant Dalal, Vipul Desai, Prem Sethi, Sujesh Vasudevan.

It is listed on the BSE with a BSE Code of 544122 , NSE with an NSE Symbol of ENTERO and ISIN of INE010601016. It's Registered office is at Plot No. I-35, Building - B,Industrial Area Phase - I,13/7 Mathura RoadFaridabad-121003, Haryana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are MSKA & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.